Angiogenesis-related downstream targets

The term 'Angiogenesis-related downstream targets' refers to a broad and non-specific category of molecular entities that function within the signaling pathways activated during new blood vessel formation. Angiogenesis is a complex process primarily regulated by the Vascular Endothelial Growth Factor (VEGF) and its receptors, which initiate intracellular cascades involving various kinases and transcription factors (Ferrara, 2004). While specific downstream effectors such as the Notch signaling components or the PI3K/Akt pathway are well-documented, this general designation lacks the molecular precision required for therapeutic targeting (Carmeliet, 2005). Because it represents a functional group rather than a single protein or enzyme, it cannot be characterized by specific drug interactions or distinct mechanisms of action. In a clinical or drug development context, identifying the specific proteins within this category is essential for developing targeted inhibitors and understanding drug resistance. Consequently, this entry is classified as incorrect for the purposes of defining a specific therapeutic target. Without a defined molecular structure, it is impossible to establish safety profiles or efficacy biomarkers for this group.

Not applicable as this is not a specific molecular target.